LIFE:aTyr Pharma Inc - Stock Price Quote and Dividend Data
LIFE STOCK PRICE LATEST CLOSE
$1.90
EXCHANGE
NASDAQ
SECTOR / SEGMENT / INDUSTRY
Health Care / Pharmaceuticals & Biotechnology / Biotechnology
aTyr Pharma Inc Dividend Information
Trailing 12 Month Dividend YieldN/A
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate (IAD)$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Split Payment TypeReverse Split
Dividend Payment TypeN/A
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend Paid1970
aTyr Pharma Inc Stock Price Information
52-Week Low/High Stock Price$1.08 - $2.45
Percent Held by Institutions70.36%
Revenue$823,000
Net Income$-69,420,000
Cash Flow$-22,380,000
EPS-0.23%
Market Cap$131,120,900
PE Ratio0
PE Ratio to Industry67%
Debt-Equity Ratio2.14%
Debt-Equity to Industry1.99%
Total Return Last 12 Months-18.10%
Total Return Last 3 Years-58.33%
Total Return Last 5 Years-66.52%
Latest Trade DateJun. 04, 2024
aTyr Pharma Inc Annual Stock Dividends
No Data available for Payment History.
aTyr Pharma Inc Dividend Payment History
| No dividends retrieved for LIFE |
aTyr Pharma Inc Other Dividend Details
aTyr Pharma is a biotherapeutics company engaged in the discovery and development of medicines based on biological pathways. Co.'s primary therapeutic candidate efzofitimod, which is a fusion protein comprised of the immunomodulatory domain of histidyl-tRNA synthetase fused to the fragment crystallizable region of a human antibody. In parallel with Co.'s clinical development of efzofitimod, Co. has been improving its discovery pipeline of NRP2 antibodies and tRNA synthetases. Co.'s investigational new drug candidate ATYR2810, which is a humanized monoclonal antibody that blocks the interaction between NRP2 and one of its primary ligands, vascular endothelial growth factor.
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryBiotechnology
Dividend AllStar™ Ranking
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
May. 23, 2024LIFE STOCK PRICE DECREASE: aTyr Pharma Inc on 05-23-2024 decreased stock price > 10% from $2.07 to $1.86
Mar. 16, 2024LIFE STOCK PRICE INCREASE: aTyr Pharma Inc on 03-16-2024 increased stock price > 10% from $1.62 to $1.99
Feb. 09, 2024LIFE STOCK PRICE INCREASE: aTyr Pharma Inc on 02-09-2024 increased stock price > 10% from $1.66 to $1.97
Dec. 20, 2023LIFE STOCK PRICE INCREASE: aTyr Pharma Inc on 12-20-2023 increased stock price > 10% from $1.27 to $1.40
Nov. 10, 2023LIFE STOCK PRICE 52 WEEK LOW: aTyr Pharma Inc on 11-10-2023 hit a 52 week low of $1.15
Oct. 20, 2023LIFE STOCK PRICE 52 WEEK LOW: aTyr Pharma Inc on 10-20-2023 hit a 52 week low of $1.28
Jun. 17, 2023LIFE STOCK PRICE INCREASE: aTyr Pharma Inc on 06-17-2023 increased stock price > 10% from $2.21 to $2.45
Apr. 25, 2023LIFE STOCK PRICE INCREASE: aTyr Pharma Inc on 04-25-2023 increased stock price > 10% from $1.88 to $2.15
Aug. 17, 2022LIFE STOCK PRICE INCREASE: aTyr Pharma Inc on 08-17-2022 increased stock price > 10% from $3.64 to $4.15
May. 12, 2022LIFE STOCK PRICE DECREASE: aTyr Pharma Inc on 05-12-2022 decreased stock price > 10% from $3.59 to $3.16
Apr. 11, 2025DIVIDEND RATE INCREASE: ADR (Sponsored)/CSL Ltd (OTCBB: CSLLY) on 04-11-2025 increased dividend rate > 3% from $1.22 to $1.28
Apr. 11, 2025KRBPQ STOCK PRICE DECREASE: Kiromic BioPharma Inc on 04-11-2025 decreased stock price > 10% from $0.12 to $0.08
Apr. 11, 2025OMGAQ STOCK PRICE DECREASE: Omega Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $0.05 to $0.04
Apr. 11, 2025ALGS STOCK PRICE DECREASE: Aligos Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $5.03 to $3.99
Apr. 11, 2025ATRA STOCK PRICE DECREASE: Atara Biotherapeutics Inc on 04-11-2025 decreased stock price > 10% from $5.89 to $5.30
Apr. 11, 2025ZVSA STOCK PRICE DECREASE: Com Par $0.001/ZyVersa Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $1.03 to $0.77
Apr. 11, 2025GERNW STOCK PRICE DECREASE: Wt Pur Com Exp 12/31/2025/Geron Corp. on 04-11-2025 decreased stock price > 10% from $0.30 to $0.27
Apr. 11, 2025RVMDW STOCK PRICE DECREASE: Wt Exp/Revolution Medicines Inc on 04-11-2025 decreased stock price > 10% from $0.05 to $0.03
Apr. 11, 2025ELUT STOCK PRICE DECREASE: Cl A Com/Elutia Inc on 04-11-2025 decreased stock price > 10% from $2.49 to $2.24
Apr. 11, 2025QNRX STOCK PRICE DECREASE: Sponsored ADR (New)/Quoin Pharmaceuticals Ltd on 04-11-2025 decreased stock price > 10% from $6.89 to $5.49
